BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3661706)

  • 21. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR; Yaksh TL; Go VL
    Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin-8 stimulates adrenocorticotropin release from anterior pituitary cells.
    Reisine T; Jensen R
    J Pharmacol Exp Ther; 1986 Mar; 236(3):621-6. PubMed ID: 2419542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cholecystokinin in the intestinal phase of pancreatic circulation in dogs.
    Nakajima M; Naruse S; Kitagawa M; Ishiguro H; Jin C; Ito O; Hayakawa T
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G614-20. PubMed ID: 11254487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A physiological role for cholecystokinin as a regulator of gastrin secretion.
    Beglinger C; Hildebrand P; Meier R; Bauerfeind P; Hasslocher H; Urscheler N; Delco F; Eberle A; Gyr K
    Gastroenterology; 1992 Aug; 103(2):490-5. PubMed ID: 1634067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
    Li P; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats.
    Jansen JB; de Jong AJ; Lamers CB
    Regul Pept; 1989 Feb; 24(2):209-13. PubMed ID: 2922496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a cholecystokinin antagonist, proglumide, on cholecystokinin-8-induced gallbladder contraction in conscious dogs.
    Fujimura M; Sakamoto T; Lluis F; Beauchamp RD; Townsend CM; Greeley GH; Thompson JC
    Biol Signals; 1992; 1(2):94-100. PubMed ID: 1307918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cholecystokinin on cytosolic calcium in pancreatic duct segments and ductal cells.
    Smith JP; Yelamarty RV; Kramer ST; Cheung JY
    Am J Physiol; 1993 Jun; 264(6 Pt 1):G1177-83. PubMed ID: 8333544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual activity increases plasma concentrations of cholecystokinin octapeptide and offsets hunger in male rats.
    Lindén A; Hansen S; Bednar I; Forsberg G; Södersten P; Uvnäs-Moberg K
    J Endocrinol; 1987 Oct; 115(1):91-5. PubMed ID: 3668450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
    White FJ; Wang RY
    Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cholecystokinin octapeptide on diacylglycerol-PKC signaling pathway in rat pulmonary interstitial macrophages stimulated by lipopolysaccharide.
    Xu SJ; Gao WJ; Cong B; Ma CL; Li SJ; Ling YL; Gu ZY; Yao YX
    Acta Pharmacol Sin; 2005 Dec; 26(12):1497-504. PubMed ID: 16297350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionally distinct receptors for cholecystokinin and gastrin on dispersed chief cells from guinea pig stomach.
    Cherner JA; Sutliff VE; Grybowski DM; Jensen RT; Gardner JD
    Am J Physiol; 1988 Feb; 254(2 Pt 1):G151-5. PubMed ID: 2831729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.